Literature DB >> 25924577

Changes in clinical trial length.

Lisette Pregelj1, Martie-Louise Verreynne1, Damian Hine1.   

Abstract

Mesh：

Year:  2015        PMID： 25924577     DOI： 10.1038/nrd4611

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  4 in total

1.  Risks and benefits of phase I liver dysfunction studies: should patients with severe liver dysfunction be included in these trials?

Authors:  Christos Fountzilas; Selena Stuart; Brian Hernandez; Elizabeth Bowhay-Carnes; Joel Michalek; John Sarantopoulos; Anand Karnad; Sukeshi Patel; Steven Weitman; Devalingam Mahalingam
Journal:  Invest New Drugs       Date:  2017-01-19       Impact factor: 3.850

2.  Clinical Trials in Hepatopancreatobiliary Surgery: Assessing Trial Characteristics, Early Discontinuation, Result Reporting, and Publication.

Authors:  Hussein H Khachfe; Joseph R Habib; Ibrahim Nassour; Hussein A Baydoun; Elie M Ghabi; Mohamad A Chahrour; Ali H Hallal; Faek R Jamali
Journal:  J Gastrointest Surg       Date:  2022-06-17       Impact factor: 3.267

3.  Trends in clinical development timeframes for antiviral drugs launched in the UK, 1981-2014: a retrospective observational study.

Authors:  Derek J Ward; Edward Hammond; Luan Linden-Phillips; Andrew J Stevens
Journal:  BMJ Open       Date:  2015-11-16       Impact factor: 2.692

4.  Clinical trials, progression-speed differentiating features and swiftness rule of the innovative targets of first-in-class drugs.

Authors:  Ying Hong Li; Xiao Xu Li; Jia Jun Hong; Yun Xia Wang; Jian Bo Fu; Hong Yang; Chun Yan Yu; Feng Cheng Li; Jie Hu; Wei Wei Xue; Yu Yang Jiang; Yu Zong Chen; Feng Zhu
Journal:  Brief Bioinform       Date:  2020-03-23       Impact factor: 11.622
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.